1. Home
  2. FGEN vs MLEC Comparison

FGEN vs MLEC Comparison

Compare FGEN & MLEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FGEN
  • MLEC
  • Stock Information
  • Founded
  • FGEN 1993
  • MLEC 2008
  • Country
  • FGEN United States
  • MLEC Luxembourg
  • Employees
  • FGEN N/A
  • MLEC N/A
  • Industry
  • FGEN Biotechnology: Pharmaceutical Preparations
  • MLEC Blank Checks
  • Sector
  • FGEN Health Care
  • MLEC Finance
  • Exchange
  • FGEN Nasdaq
  • MLEC Nasdaq
  • Market Cap
  • FGEN 34.5M
  • MLEC 23.9M
  • IPO Year
  • FGEN 2014
  • MLEC N/A
  • Fundamental
  • Price
  • FGEN $0.55
  • MLEC $0.63
  • Analyst Decision
  • FGEN
  • MLEC
  • Analyst Count
  • FGEN 0
  • MLEC 0
  • Target Price
  • FGEN N/A
  • MLEC N/A
  • AVG Volume (30 Days)
  • FGEN 709.3K
  • MLEC 10.8K
  • Earning Date
  • FGEN 02-24-2025
  • MLEC 03-12-2025
  • Dividend Yield
  • FGEN N/A
  • MLEC N/A
  • EPS Growth
  • FGEN N/A
  • MLEC N/A
  • EPS
  • FGEN N/A
  • MLEC N/A
  • Revenue
  • FGEN $180,015,000.00
  • MLEC $5,625,124.00
  • Revenue This Year
  • FGEN $21.91
  • MLEC $20.42
  • Revenue Next Year
  • FGEN N/A
  • MLEC $30.00
  • P/E Ratio
  • FGEN N/A
  • MLEC N/A
  • Revenue Growth
  • FGEN 16.15
  • MLEC 521.53
  • 52 Week Low
  • FGEN $0.18
  • MLEC $0.53
  • 52 Week High
  • FGEN $2.80
  • MLEC $3.25
  • Technical
  • Relative Strength Index (RSI)
  • FGEN 54.38
  • MLEC 31.49
  • Support Level
  • FGEN $0.46
  • MLEC $0.53
  • Resistance Level
  • FGEN $0.51
  • MLEC $0.60
  • Average True Range (ATR)
  • FGEN 0.04
  • MLEC 0.05
  • MACD
  • FGEN -0.00
  • MLEC -0.02
  • Stochastic Oscillator
  • FGEN 93.75
  • MLEC 20.65

About FGEN FibroGen Inc

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The Company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates.

About MLEC Moolec Science SA

Moolec Science SA is a science-based ingredient company focused on producing real animal proteins in plants through Molecular Farming, a technology in the alternative protein landscape. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system. The company has various products in its pipeline such as; TSP Valorasoy which is a soy protein product to produce vegetable proteins with texture and fibrousness similar to those of meat, Glaso, a safflower oil with high levels of gamma-linolenic acid, SPC2 which is a plant-based chymosin, YEEA1, an extract derived from a novel yeast biomass with specific properties, and others. The company's revenues arise from operations in Argentina.

Share on Social Networks: